In the context of C9orf72-ALS [65], N6-methyladenosine (m6A), the primary common internal mRNA modification, is reduced in C9orf72-ALS, both in patient-derived induced pluripotent stem cell (iPSC)-differentiated neurons, and postmortem brain tissues. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.